{"transactions":[{"id":4626899,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68719,"kind":"person","name":"Burrows Francis","position":1,"cik":"0002051119","reported_name":"Burrows Francis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-25T20:05:07.000Z","date":"2026-09-24","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.15,"expiration_date":"2027-01-22","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-402815","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2051119/000119312526402815/ownership.xml","form_type":"4"}},{"id":4626898,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68719,"kind":"person","name":"Burrows Francis","position":1,"cik":"0002051119","reported_name":"Burrows Francis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-25T20:05:07.000Z","date":"2026-09-24","kind":"sale","planned":false,"acquired":false,"shares":20726,"price":10.8325,"value":224514.395,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $10.82 to $10.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":42327,"source":{"system":"sec-edgar","filing":"0001193125-26-402815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2051119/000119312526402815/ownership.xml","form_type":"4"}},{"id":4626897,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68719,"kind":"person","name":"Burrows Francis","position":1,"cik":"0002051119","reported_name":"Burrows Francis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-25T20:05:07.000Z","date":"2026-09-24","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":6.15,"value":184500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cashless exercise and sale of a portion of a stock option to cover estimated payroll tax liability."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 629 shares acquired on May 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":63053,"source":{"system":"sec-edgar","filing":"0001193125-26-402815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051119/000119312526402815/ownership.xml","form_type":"4"}},{"id":4614722,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":46491,"kind":"person","name":"Fulk Jennifer","position":1,"cik":"0001873522","reported_name":"Fulk Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase common stock","published_at":"2026-09-10T20:30:03.000Z","date":"2026-09-08","kind":"grant","planned":true,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter."}],"balance_after":450000,"derivative":{"exercise_price":12.52,"expiration_date":"2036-09-07","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001193125-26-387934","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873522/000119312526387934/ownership.xml","form_type":"4"}},{"id":677294,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-24T21:30:03.000Z","date":"2026-08-24","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":12.39,"value":1239000.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $11.47 to $12.85. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":479194,"source":{"system":"sec-edgar","filing":"0001193125-26-363812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526363812/ownership.xml","form_type":"4"}},{"id":677293,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-24T21:30:03.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":4345,"price":11.8903,"value":51663.3535,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $11.78 to $12.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":169269,"source":{"system":"sec-edgar","filing":"0001193125-26-363810","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526363810/ownership.xml","form_type":"4"}},{"id":678898,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-08-21T20:30:11.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":31487,"price":12.63,"value":397680.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares sold were acquired by the Reporting Person upon vesting of restricted stock units during the period from January 26, 2024 through January 26, 2026. The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $12.44 to $12.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":195444,"source":{"system":"sec-edgar","filing":"0001193125-26-361184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526361184/ownership.xml","form_type":"4"}},{"id":685351,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-17T20:45:03.000Z","date":"2026-08-17","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":11.12,"value":1112000.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $10.87 to $11.31. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":379194,"source":{"system":"sec-edgar","filing":"0001193125-26-354201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526354201/ownership.xml","form_type":"4"}},{"id":730825,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-22T22:00:03.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":84929,"price":9.8233,"value":834283.0457,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares sold were acquired by the Reporting Person upon vesting of restricted stock units and performance restricted stock units during the period from January 26, 2022 through January 26, 2026. The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.56 to $9.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":182345,"source":{"system":"sec-edgar","filing":"0001193125-26-277780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000119312526277780/ownership.xml","form_type":"4"}},{"id":749462,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-06-04T22:30:15.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":8.77,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-257903","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526257903/ownership.xml","form_type":"4"}},{"id":749461,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41321,"kind":"person","name":"VASCONCELLES MICHAEL","position":1,"cik":"0001734755","reported_name":"VASCONCELLES MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-06-04T22:30:14.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":8.77,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-257902","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526257902/ownership.xml","form_type":"4"}},{"id":749460,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":19447,"kind":"person","name":"Hasnain Faheem","position":1,"cik":"0001352620","reported_name":"Hasnain Faheem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-06-04T22:30:12.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":8.77,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-257901","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526257901/ownership.xml","form_type":"4"}},{"id":749459,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":21637,"kind":"person","name":"Collins Helen Louise","position":1,"cik":"0001701247","reported_name":"Collins Helen Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-06-04T22:30:10.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":8.77,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-257900","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526257900/ownership.xml","form_type":"4"}},{"id":749458,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-06-04T22:30:05.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":8.77,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-257898","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526257898/ownership.xml","form_type":"4"}},{"id":749457,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-06-04T22:30:04.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":8.77,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-257897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526257897/ownership.xml","form_type":"4"}},{"id":749456,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-06-04T22:30:02.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":8.77,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-257896","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526257896/ownership.xml","form_type":"4"}},{"id":765756,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:05:07.000Z","date":"2026-05-21","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":11,"value":110000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025."}],"balance_after":173614,"source":{"system":"sec-edgar","filing":"0001193125-26-236838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526236838/ownership.xml","form_type":"4"}},{"id":769868,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:05:22.000Z","date":"2026-05-19","kind":"sale","planned":true,"acquired":false,"shares":339,"price":9.21,"value":3122.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"678 shares were acquired on May 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":183614,"source":{"system":"sec-edgar","filing":"0001193125-26-232547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526232547/ownership.xml","form_type":"4"}},{"id":769867,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":45643,"kind":"person","name":"FORD KATHLEEN","position":1,"cik":"0001785406","reported_name":"FORD KATHLEEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:05:20.000Z","date":"2026-05-19","kind":"sale","planned":true,"acquired":false,"shares":2257,"price":9.0752,"value":20482.7264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"2,257 shares were acquired on May 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $8.97 to $9.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":153560,"source":{"system":"sec-edgar","filing":"0001193125-26-232548","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526232548/ownership.xml","form_type":"4"}},{"id":770111,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:05:18.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":2256,"price":9.3795,"value":21160.152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"2,256 shares were acquired on May 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.28 to $9.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":226931,"source":{"system":"sec-edgar","filing":"0001193125-26-232546","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526232546/ownership.xml","form_type":"4"}},{"id":828179,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-25T13:00:03.000Z","date":"2026-03-23","kind":"exercise","planned":false,"acquired":true,"shares":6103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents stock options exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.15,"expiration_date":"2027-01-22","underlying":"Common Stock","underlying_shares":6103},"source":{"system":"sec-edgar","filing":"0001193125-26-122938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526122938/ownership.xml","form_type":"4"}},{"id":828178,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-25T13:00:03.000Z","date":"2026-03-23","kind":"exercise","planned":false,"acquired":true,"shares":6103,"price":6.15,"value":37533.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents stock options exercised."}],"balance_after":435456,"source":{"system":"sec-edgar","filing":"0001193125-26-122938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526122938/ownership.xml","form_type":"4"}},{"id":832274,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T13:00:03.000Z","date":"2026-03-18","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents stock options exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.12,"expiration_date":"2026-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-116834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526116834/ownership.xml","form_type":"4"}},{"id":832273,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T13:00:03.000Z","date":"2026-03-18","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":3.12,"value":31200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents stock options exercised."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001193125-26-116834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526116834/ownership.xml","form_type":"4"}},{"id":929920,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:08.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":1572,"price":8.4607,"value":13300.2204,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24."}],"balance_after":183275,"source":{"system":"sec-edgar","filing":"0001193125-26-025305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025305/ownership.xml","form_type":"4"}},{"id":929919,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:08.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":4842,"price":8.4606,"value":40966.2252,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25."}],"balance_after":184847,"source":{"system":"sec-edgar","filing":"0001193125-26-025305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025305/ownership.xml","form_type":"4"}},{"id":929922,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":45643,"kind":"person","name":"FORD KATHLEEN","position":1,"cik":"0001785406","reported_name":"FORD KATHLEEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:07.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":1813,"price":8.4607,"value":15339.2491,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22."}],"balance_after":153560,"source":{"system":"sec-edgar","filing":"0001193125-26-025304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025304/ownership.xml","form_type":"4"}},{"id":930189,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:05.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":1341,"price":8.4607,"value":11345.7987,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22."}],"balance_after":267274,"source":{"system":"sec-edgar","filing":"0001193125-26-025303","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000119312526025303/ownership.xml","form_type":"4"}},{"id":930188,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:05.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":951,"price":8.4607,"value":8046.1257,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23."}],"balance_after":268615,"source":{"system":"sec-edgar","filing":"0001193125-26-025303","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000119312526025303/ownership.xml","form_type":"4"}},{"id":930187,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:05.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":2233,"price":8.4607,"value":18892.7431,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/24."}],"balance_after":269566,"source":{"system":"sec-edgar","filing":"0001193125-26-025303","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000119312526025303/ownership.xml","form_type":"4"}},{"id":930186,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:05.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":3655,"price":8.4607,"value":30923.8585,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25."}],"balance_after":271799,"source":{"system":"sec-edgar","filing":"0001193125-26-025303","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000119312526025303/ownership.xml","form_type":"4"}},{"id":929918,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:04.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":881,"price":8.4607,"value":7453.8767,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F5","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22."}],"balance_after":145167,"source":{"system":"sec-edgar","filing":"0001193125-26-025302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025302/ownership.xml","form_type":"4"}},{"id":929917,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:04.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":2226,"price":8.4607,"value":18833.5182,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25."}],"balance_after":146048,"source":{"system":"sec-edgar","filing":"0001193125-26-025302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025302/ownership.xml","form_type":"4"}},{"id":929916,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:04.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":695,"price":8.4607,"value":5880.1865,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22."}],"balance_after":148274,"source":{"system":"sec-edgar","filing":"0001193125-26-025302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025302/ownership.xml","form_type":"4"}},{"id":929915,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:04.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":1114,"price":8.4607,"value":9425.2198,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23."}],"balance_after":148969,"source":{"system":"sec-edgar","filing":"0001193125-26-025302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025302/ownership.xml","form_type":"4"}},{"id":929914,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:04.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":2226,"price":8.4607,"value":18833.5182,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24."}],"balance_after":150083,"source":{"system":"sec-edgar","filing":"0001193125-26-025302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025302/ownership.xml","form_type":"4"}},{"id":930105,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:02.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":4777,"price":8.4607,"value":40416.7639,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24."}],"balance_after":226931,"source":{"system":"sec-edgar","filing":"0001193125-26-025301","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526025301/ownership.xml","form_type":"4"}},{"id":930104,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:02.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":2335,"price":8.4607,"value":19755.7345,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23."}],"balance_after":231708,"source":{"system":"sec-edgar","filing":"0001193125-26-025301","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526025301/ownership.xml","form_type":"4"}},{"id":930103,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:02.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":4096,"price":8.4607,"value":34655.0272,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25."}],"balance_after":234043,"source":{"system":"sec-edgar","filing":"0001193125-26-025301","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526025301/ownership.xml","form_type":"4"}},{"id":930185,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68719,"kind":"person","name":"Burrows Francis","position":1,"cik":"0002051119","reported_name":"Burrows Francis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-27T21:35:03.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":1311,"price":8.4607,"value":11091.9777,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22."}],"balance_after":32424,"source":{"system":"sec-edgar","filing":"0001193125-26-025306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051119/000119312526025306/ownership.xml","form_type":"4"}},{"id":946216,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T21:31:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":1120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":1120000,"derivative":{"exercise_price":10.335,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":1120000},"source":{"system":"sec-edgar","filing":"0001193125-26-004580","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004580/ownership.xml","form_type":"4"}},{"id":947396,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T21:30:16.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":100000,"derivative":{"exercise_price":10.335,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-004570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000119312526004570/ownership.xml","form_type":"4"}},{"id":947395,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:16.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30."}],"balance_after":275454,"source":{"system":"sec-edgar","filing":"0001193125-26-004570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000119312526004570/ownership.xml","form_type":"4"}},{"id":946215,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T21:30:15.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":42500,"derivative":{"exercise_price":10.335,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001193125-26-004569","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004569/ownership.xml","form_type":"4"}},{"id":946214,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:15.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 802 shares acquired on November 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":152309,"source":{"system":"sec-edgar","filing":"0001193125-26-004569","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004569/ownership.xml","form_type":"4"}},{"id":946213,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":45643,"kind":"person","name":"FORD KATHLEEN","position":1,"cik":"0001785406","reported_name":"FORD KATHLEEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T21:30:12.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":100000,"derivative":{"exercise_price":10.335,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-004567","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004567/ownership.xml","form_type":"4"}},{"id":946212,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":45643,"kind":"person","name":"FORD KATHLEEN","position":1,"cik":"0001785406","reported_name":"FORD KATHLEEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:12.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30."}],"balance_after":155373,"source":{"system":"sec-edgar","filing":"0001193125-26-004567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004567/ownership.xml","form_type":"4"}},{"id":946211,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T21:30:07.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":100000,"derivative":{"exercise_price":10.335,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-004564","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004564/ownership.xml","form_type":"4"}},{"id":946210,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:07.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30."}],"balance_after":189689,"source":{"system":"sec-edgar","filing":"0001193125-26-004564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004564/ownership.xml","form_type":"4"}},{"id":946960,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T21:30:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":100000,"derivative":{"exercise_price":10.335,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-004562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526004562/ownership.xml","form_type":"4"}},{"id":946959,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30."}],"balance_after":238139,"source":{"system":"sec-edgar","filing":"0001193125-26-004562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312526004562/ownership.xml","form_type":"4"}},{"id":947390,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68719,"kind":"person","name":"Burrows Francis","position":1,"cik":"0002051119","reported_name":"Burrows Francis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T16:30:08.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":185000,"derivative":{"exercise_price":10.335,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001193125-26-004566","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051119/000119312526004566/ownership.xml","form_type":"4"}},{"id":962259,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68719,"kind":"person","name":"Burrows Francis","position":1,"cik":"0002051119","reported_name":"Burrows Francis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T16:30:04.000Z","date":"2025-12-18","kind":"exercise","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cashless exercise and sale of a portion of a stock option to cover estimated payroll tax liability."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.8,"expiration_date":"2026-01-29","underlying":"Common stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-25-326948","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2051119/000119312525326948/ownership.xml","form_type":"4"}},{"id":962258,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68719,"kind":"person","name":"Burrows Francis","position":1,"cik":"0002051119","reported_name":"Burrows Francis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:30:04.000Z","date":"2025-12-18","kind":"sale","planned":false,"acquired":false,"shares":23726,"price":9.7754,"value":231931.1404,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.77 to $9.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":33735,"source":{"system":"sec-edgar","filing":"0001193125-25-326948","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2051119/000119312525326948/ownership.xml","form_type":"4"}},{"id":962257,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68719,"kind":"person","name":"Burrows Francis","position":1,"cik":"0002051119","reported_name":"Burrows Francis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:30:04.000Z","date":"2025-12-18","kind":"exercise","planned":false,"acquired":true,"shares":35000,"price":4.8,"value":168000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cashless exercise and sale of a portion of a stock option to cover estimated payroll tax liability."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 857 shares acquired on May 17, 2025 and 899 shares acquired on November 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":57461,"source":{"system":"sec-edgar","filing":"0001193125-25-326948","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051119/000119312525326948/ownership.xml","form_type":"4"}},{"id":974358,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":19447,"kind":"person","name":"Hasnain Faheem","position":1,"cik":"0001352620","reported_name":"Hasnain Faheem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T21:05:03.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":10.9764,"value":109764.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.60 to $11.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23983,"source":{"system":"sec-edgar","filing":"0001193125-25-314154","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525314154/ownership.xml","form_type":"4"}},{"id":974357,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":19447,"kind":"person","name":"Hasnain Faheem","position":1,"cik":"0001352620","reported_name":"Hasnain Faheem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T21:05:03.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":3.12,"value":31200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025."}],"balance_after":33983,"source":{"system":"sec-edgar","filing":"0001193125-25-314154","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525314154/ownership.xml","form_type":"4"}},{"id":998946,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:13.000Z","date":"2025-11-14","kind":"sale","planned":true,"acquired":false,"shares":8804,"price":11.1769,"value":98401.4276,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":188139,"source":{"system":"sec-edgar","filing":"0001193125-25-283568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312525283568/ownership.xml","form_type":"4"}},{"id":998945,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:13.000Z","date":"2025-11-13","kind":"grant","planned":true,"acquired":true,"shares":48900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":196943,"source":{"system":"sec-edgar","filing":"0001193125-25-283568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312525283568/ownership.xml","form_type":"4"}},{"id":998806,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:10.000Z","date":"2025-11-13","kind":"grant","planned":false,"acquired":true,"shares":182500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 1/3rd of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":429353,"source":{"system":"sec-edgar","filing":"0001193125-25-283565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283565/ownership.xml","form_type":"4"}},{"id":998805,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:08.000Z","date":"2025-11-14","kind":"sale","planned":false,"acquired":false,"shares":8887,"price":11.1769,"value":99329.1103,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 11/13/25."}],"balance_after":139689,"source":{"system":"sec-edgar","filing":"0001193125-25-283564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283564/ownership.xml","form_type":"4"}},{"id":998804,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:08.000Z","date":"2025-11-13","kind":"grant","planned":false,"acquired":true,"shares":48900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest 50% immediately and 50% on 11/13/26."}],"balance_after":148576,"source":{"system":"sec-edgar","filing":"0001193125-25-283564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283564/ownership.xml","form_type":"4"}},{"id":999091,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:06.000Z","date":"2025-11-14","kind":"sale","planned":false,"acquired":false,"shares":15485,"price":11.1769,"value":173074.2965,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023 and January 2, 2025.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":225454,"source":{"system":"sec-edgar","filing":"0001193125-25-283563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000119312525283563/ownership.xml","form_type":"4"}},{"id":999090,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:06.000Z","date":"2025-11-13","kind":"grant","planned":false,"acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":240939,"source":{"system":"sec-edgar","filing":"0001193125-25-283563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000119312525283563/ownership.xml","form_type":"4"}},{"id":998801,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:05.000Z","date":"2025-11-14","kind":"sale","planned":false,"acquired":false,"shares":4539,"price":11.1769,"value":50731.9491,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":130257,"source":{"system":"sec-edgar","filing":"0001193125-25-283562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283562/ownership.xml","form_type":"4"}},{"id":998800,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:05.000Z","date":"2025-11-13","kind":"grant","planned":false,"acquired":true,"shares":24967,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":134796,"source":{"system":"sec-edgar","filing":"0001193125-25-283562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283562/ownership.xml","form_type":"4"}},{"id":998803,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":45643,"kind":"person","name":"FORD KATHLEEN","position":1,"cik":"0001785406","reported_name":"FORD KATHLEEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:03.000Z","date":"2025-11-14","kind":"sale","planned":true,"acquired":false,"shares":6902,"price":11.1769,"value":77142.9638,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":105373,"source":{"system":"sec-edgar","filing":"0001193125-25-283560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283560/ownership.xml","form_type":"4"}},{"id":998802,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":45643,"kind":"person","name":"FORD KATHLEEN","position":1,"cik":"0001785406","reported_name":"FORD KATHLEEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:03.000Z","date":"2025-11-13","kind":"grant","planned":true,"acquired":true,"shares":48900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":112275,"source":{"system":"sec-edgar","filing":"0001193125-25-283560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283560/ownership.xml","form_type":"4"}},{"id":1031161,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:10.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":8891,"price":8.9422,"value":79505.1002,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 9/27/25."}],"balance_after":99676,"source":{"system":"sec-edgar","filing":"0001193125-25-223667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223667/ownership.xml","form_type":"4"}},{"id":1031160,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:10.000Z","date":"2025-09-27","kind":"grant","planned":false,"acquired":true,"shares":48900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":108567,"source":{"system":"sec-edgar","filing":"0001193125-25-223667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223667/ownership.xml","form_type":"4"}},{"id":1031268,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:08.000Z","date":"2025-09-29","kind":"sale","planned":true,"acquired":false,"shares":8805,"price":8.9422,"value":78736.071,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":148043,"source":{"system":"sec-edgar","filing":"0001193125-25-223666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312525223666/ownership.xml","form_type":"4"}},{"id":1031267,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:08.000Z","date":"2025-09-27","kind":"grant","planned":true,"acquired":true,"shares":48900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":156848,"source":{"system":"sec-edgar","filing":"0001193125-25-223666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000119312525223666/ownership.xml","form_type":"4"}},{"id":1031159,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":45643,"kind":"person","name":"FORD KATHLEEN","position":1,"cik":"0001785406","reported_name":"FORD KATHLEEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:07.000Z","date":"2025-09-29","kind":"sale","planned":true,"acquired":false,"shares":6892,"price":8.9422,"value":61629.6424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":63375,"source":{"system":"sec-edgar","filing":"0001193125-25-223665","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223665/ownership.xml","form_type":"4"}},{"id":1031158,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":45643,"kind":"person","name":"FORD KATHLEEN","position":1,"cik":"0001785406","reported_name":"FORD KATHLEEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:07.000Z","date":"2025-09-27","kind":"grant","planned":true,"acquired":false,"shares":48900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70267,"source":{"system":"sec-edgar","filing":"0001193125-25-223665","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223665/ownership.xml","form_type":"4"}},{"id":1031325,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:05.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":12314,"price":8.9422,"value":110114.2508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023 and January 2, 2025.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":158439,"source":{"system":"sec-edgar","filing":"0001193125-25-223664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000119312525223664/ownership.xml","form_type":"4"}},{"id":1031324,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:05.000Z","date":"2025-09-27","kind":"grant","planned":false,"acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":170753,"source":{"system":"sec-edgar","filing":"0001193125-25-223664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000119312525223664/ownership.xml","form_type":"4"}},{"id":1031157,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:04.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":36615,"price":8.9422,"value":327418.653,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":246853,"source":{"system":"sec-edgar","filing":"0001193125-25-223663","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223663/ownership.xml","form_type":"4"}},{"id":1031156,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:04.000Z","date":"2025-09-27","kind":"grant","planned":false,"acquired":true,"shares":182500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":283468,"source":{"system":"sec-edgar","filing":"0001193125-25-223663","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223663/ownership.xml","form_type":"4"}},{"id":1031155,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:02.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":4541,"price":8.9422,"value":40606.5302,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":109829,"source":{"system":"sec-edgar","filing":"0001193125-25-223662","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223662/ownership.xml","form_type":"4"}},{"id":1031154,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:02.000Z","date":"2025-09-27","kind":"grant","planned":false,"acquired":true,"shares":24966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,211 shares acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":114370,"source":{"system":"sec-edgar","filing":"0001193125-25-223662","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223662/ownership.xml","form_type":"4"}},{"id":1044723,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-09T20:28:40.000Z","date":"2025-09-08","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":8.2029,"value":410145.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $8.135 to $8.24. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakesto provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":100968,"source":{"system":"sec-edgar","filing":"0001415889-25-023974","document":"form4-09092025_080937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000141588925023974/form4-09092025_080937.xml","form_type":"4"}},{"id":1066314,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-14T20:05:05.000Z","date":"2025-08-13","kind":"purchase","planned":false,"acquired":true,"shares":13494,"price":6.6417,"value":89623.0998,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $6.485 to $6.735. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50968,"source":{"system":"sec-edgar","filing":"0000950170-25-108844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025108844/ownership.xml","form_type":"4"}},{"id":1066313,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-14T20:05:05.000Z","date":"2025-08-12","kind":"purchase","planned":false,"acquired":true,"shares":36506,"price":5.8505,"value":213578.353,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $5.56 to $5.995. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 409 shares acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":37474,"source":{"system":"sec-edgar","filing":"0000950170-25-108844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025108844/ownership.xml","form_type":"4"}},{"id":1119470,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":21637,"kind":"person","name":"Collins Helen Louise","position":1,"cik":"0001701247","reported_name":"Collins Helen Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-06-06T20:05:24.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":28500,"derivative":{"exercise_price":6.57,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0000950170-25-083041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025083041/ownership.xml","form_type":"4"}},{"id":1119472,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41322,"kind":"person","name":"Parks Diane L.","position":1,"cik":"0001781026","reported_name":"Parks Diane L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-06-06T20:05:18.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":28500,"derivative":{"exercise_price":6.57,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0000950170-25-083040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025083040/ownership.xml","form_type":"4"}},{"id":1119468,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41321,"kind":"person","name":"VASCONCELLES MICHAEL","position":1,"cik":"0001734755","reported_name":"VASCONCELLES MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-06-06T20:05:15.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":28500,"derivative":{"exercise_price":6.57,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0000950170-25-083037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025083037/ownership.xml","form_type":"4"}},{"id":1119469,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-06-06T20:05:12.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":28500,"derivative":{"exercise_price":6.57,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0000950170-25-083038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025083038/ownership.xml","form_type":"4"}},{"id":1119467,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":19447,"kind":"person","name":"Hasnain Faheem","position":1,"cik":"0001352620","reported_name":"Hasnain Faheem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-06-06T20:05:11.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":28500,"derivative":{"exercise_price":6.57,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0000950170-25-083039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025083039/ownership.xml","form_type":"4"}},{"id":1119466,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-06-06T20:05:08.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":28500,"derivative":{"exercise_price":6.57,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0000950170-25-083036","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025083036/ownership.xml","form_type":"4"}},{"id":1119465,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":16829,"kind":"person","name":"Szela Mary T","position":1,"cik":"0001410289","reported_name":"Szela Mary T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-06-06T20:05:05.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":28500,"derivative":{"exercise_price":6.57,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0000950170-25-083035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025083035/ownership.xml","form_type":"4"}},{"id":1142933,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20869,"kind":"person","name":"Bair Teresa Brophy","position":1,"cik":"0001813058","reported_name":"Bair Teresa Brophy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-05-19T22:30:08.000Z","date":"2025-05-19","kind":"sale","planned":true,"acquired":false,"shares":1559,"price":5.96,"value":9291.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"1,559 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":107948,"source":{"system":"sec-edgar","filing":"0000950170-25-074660","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813058/000095017025074660/ownership.xml","form_type":"4"}},{"id":1142430,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":45643,"kind":"person","name":"FORD KATHLEEN","position":1,"cik":"0001785406","reported_name":"FORD KATHLEEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-05-19T22:30:04.000Z","date":"2025-05-19","kind":"sale","planned":true,"acquired":false,"shares":1558,"price":6.2756,"value":9777.3848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"1,558 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $6.27 to $6.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21367,"source":{"system":"sec-edgar","filing":"0000950170-25-074659","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025074659/ownership.xml","form_type":"4"}},{"id":1193328,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":19447,"kind":"person","name":"Hasnain Faheem","position":1,"cik":"0001352620","reported_name":"Hasnain Faheem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-24T20:33:39.000Z","date":"2025-03-21","kind":"sale","planned":false,"acquired":false,"shares":22682,"price":8,"value":181456.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 20, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $8.00 to $8.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23983,"source":{"system":"sec-edgar","filing":"0000950170-25-043903","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025043903/ownership.xml","form_type":"4"}},{"id":1193327,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":19447,"kind":"person","name":"Hasnain Faheem","position":1,"cik":"0001352620","reported_name":"Hasnain Faheem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-24T20:33:39.000Z","date":"2025-03-21","kind":"exercise","planned":false,"acquired":true,"shares":22682,"price":6.32,"value":143350.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 20, 2024."}],"balance_after":46665,"source":{"system":"sec-edgar","filing":"0000950170-25-043903","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025043903/ownership.xml","form_type":"4"}},{"id":1292966,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-01-29T01:54:15.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":1122,"price":7.8719,"value":8832.2718,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23."}],"balance_after":88193,"source":{"system":"sec-edgar","filing":"0000950170-25-010137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025010137/ownership.xml","form_type":"4"}},{"id":1292965,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-01-29T01:54:15.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":699,"price":7.8719,"value":5502.4581,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22."}],"balance_after":89315,"source":{"system":"sec-edgar","filing":"0000950170-25-010137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025010137/ownership.xml","form_type":"4"}},{"id":1292964,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-01-29T01:54:15.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":887,"price":7.8719,"value":6982.3753,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22."}],"balance_after":90014,"source":{"system":"sec-edgar","filing":"0000950170-25-010137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025010137/ownership.xml","form_type":"4"}},{"id":1292963,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-01-29T01:54:15.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":2241,"price":7.8719,"value":17640.9279,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24."}],"balance_after":90901,"source":{"system":"sec-edgar","filing":"0000950170-25-010137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025010137/ownership.xml","form_type":"4"}},{"id":1293304,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-29T01:39:01.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":541,"price":7.8719,"value":4258.6979,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/21."}],"balance_after":88253,"source":{"system":"sec-edgar","filing":"0000950170-25-010121","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000095017025010121/ownership.xml","form_type":"4"}},{"id":1293303,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36439,"kind":"person","name":"Leoni Mollie","position":1,"cik":"0002051106","reported_name":"Leoni Mollie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-29T01:39:01.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":816,"price":7.8719,"value":6423.4704,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23."}],"balance_after":88794,"source":{"system":"sec-edgar","filing":"0000950170-25-010121","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2051106/000095017025010121/ownership.xml","form_type":"4"}}],"next_cursor":"2025-01-29T01:39:01.000000Z,1293303"}